Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaming Li

Showing results (241-250 of 280) with videos related to

Pageof 28
Sort By:
Hepatology (Baltimore, Md.)|February 26, 2017
PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidationWen Zhang, Jieliang Chen, Min Wu, et al.
Cell Cycle (Georgetown, Tex.)|January 19, 2021
USP1-WDR48 deubiquitinase complex enhances TGF-β induced epithelial-mesenchymal transition of TNBC cells via stabilizing TAK1Dianwen Han, Lijuan Wang, Bing Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2021
circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathwayYaming Li, Zekun Wang, Peng Su, et al.
Cell Death and Differentiation|July 24, 2025
The USP1-WDR48 deubiquitinase complex functions as a molecular switch regulating tumor-associated macrophage activation and anti-tumor responseDianwen Han, Lijuan Wang, Shan Jiang, et al.
Oncogene|March 14, 2021
CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocationTong Chen, Xiaolong Wang, Chen Li, et al.
Molecular Therapy. Nucleic Acids|November 17, 2021
DGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancerYiran Liang, Fangzhou Ye, Yajie Wang, et al.
Frontiers in Oncology|April 19, 2021
LINC01977 Promotes Breast Cancer Progression and Chemoresistance to Doxorubicin by Targeting miR-212-3p/GOLM1 AxisZheng Li, Yaming Li, Xiaolong Wang, et al.
Journal of General Internal Medicine|May 31, 2024
Racial and Ethnic Differences in Health Care Experiences for Veterans Receiving VA Community Care from 2016 to 2021Sudarshan Krishnamurthy, Yaming Li, Florentina Sileanu, et al.
Journal of Thoracic Disease|November 13, 2025
Efficacy, pharmacokinetics, and safety of nebulized HL231 inhalation solution in patients with chronic obstructive pulmonary disease: a randomized trialQingyuan Hu, Li Zhao, Guoping Yang, et al.
Drug Design, Development and Therapy|September 14, 2020
Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast CancerYing Liu, Ning Zhang, Hanwen Zhang, et al.
Pageof 28

Showing results (241-250 of 280) with videos related to

Sort By:
Pageof 28
Hepatology (Baltimore, Md.)|February 26, 2017
PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidationWen Zhang, Jieliang Chen, Min Wu, et al.
Cell Cycle (Georgetown, Tex.)|January 19, 2021
USP1-WDR48 deubiquitinase complex enhances TGF-β induced epithelial-mesenchymal transition of TNBC cells via stabilizing TAK1Dianwen Han, Lijuan Wang, Bing Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2021
circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathwayYaming Li, Zekun Wang, Peng Su, et al.
Cell Death and Differentiation|July 24, 2025
The USP1-WDR48 deubiquitinase complex functions as a molecular switch regulating tumor-associated macrophage activation and anti-tumor responseDianwen Han, Lijuan Wang, Shan Jiang, et al.
Oncogene|March 14, 2021
CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocationTong Chen, Xiaolong Wang, Chen Li, et al.
Molecular Therapy. Nucleic Acids|November 17, 2021
DGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancerYiran Liang, Fangzhou Ye, Yajie Wang, et al.
Frontiers in Oncology|April 19, 2021
LINC01977 Promotes Breast Cancer Progression and Chemoresistance to Doxorubicin by Targeting miR-212-3p/GOLM1 AxisZheng Li, Yaming Li, Xiaolong Wang, et al.
Journal of General Internal Medicine|May 31, 2024
Racial and Ethnic Differences in Health Care Experiences for Veterans Receiving VA Community Care from 2016 to 2021Sudarshan Krishnamurthy, Yaming Li, Florentina Sileanu, et al.
Journal of Thoracic Disease|November 13, 2025
Efficacy, pharmacokinetics, and safety of nebulized HL231 inhalation solution in patients with chronic obstructive pulmonary disease: a randomized trialQingyuan Hu, Li Zhao, Guoping Yang, et al.
Drug Design, Development and Therapy|September 14, 2020
Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast CancerYing Liu, Ning Zhang, Hanwen Zhang, et al.
Pageof 28